期刊文献+

RELEASE OF IBUPROFEN FROM PEG-PLLA ELECTROSPUN FIBERS CONTAINING POLY(ETHYLENE GLYCOL)-b-POLY(α-HYDROXY OCTANOIC ACID) AS AN ADDITIVE 被引量:1

RELEASE OF IBUPROFEN FROM PEG-PLLA ELECTROSPUN FIBERS CONTAINING POLY(ETHYLENE GLYCOL)-b-POLY(α-HYDROXY OCTANOIC ACID) AS AN ADDITIVE
下载PDF
导出
摘要 Poly(a-hydroxy octanoic acid) was first used as an additive for the preparation of electrospun ultra-fine fibers of poly(ethylene glycol)-b-poly(L-lactide) (PEG-PLLA). Ibuprofen was loaded in the electrospun ultra-fine fibers. The results from environmental scanning electron microscopy (ESEM), wide angle X-ray diffraction (WAXD) and differential scanning calorimetry (DSC) demonstrated that ibuprofen could be perfectly entrapped in the fibers electrospun from PEG-PLLA using a-hydroxy octanoic acid or PEG-b-poly(a-hydroxy octanoic acid) (PEG-PHOA) as additives. Compared with electrospun PEG-PLLA fibers which entrapped 20 wt% ibuprofen, the PEG-PLLA electrospun fibers containing PEG-PHOA exhibited integral and robust after 1 week incubated in 37℃, pH 7.4 phosphate buffer solution with 10 μg/mL proteinase K. Compared with electrospun fibers without PEG-PHOA, the concentration ofproteinase K in release media had less effect on the release rate of ibuprofen. An unique release profile was found from PEG-PLLA fiber after the incorporation of PEG-PHOA. Enzyme degradation experiments demonstrated that PEG-PHOA but not a-hydroxy octanoic acid monomer was the crucial factor for integrity maintenance of the electrospun fibers, which may be due to the enzyme degradation tolerance property of the PEG-PHOA polymer additive. Poly(a-hydroxy octanoic acid) was first used as an additive for the preparation of electrospun ultra-fine fibers of poly(ethylene glycol)-b-poly(L-lactide) (PEG-PLLA). Ibuprofen was loaded in the electrospun ultra-fine fibers. The results from environmental scanning electron microscopy (ESEM), wide angle X-ray diffraction (WAXD) and differential scanning calorimetry (DSC) demonstrated that ibuprofen could be perfectly entrapped in the fibers electrospun from PEG-PLLA using a-hydroxy octanoic acid or PEG-b-poly(a-hydroxy octanoic acid) (PEG-PHOA) as additives. Compared with electrospun PEG-PLLA fibers which entrapped 20 wt% ibuprofen, the PEG-PLLA electrospun fibers containing PEG-PHOA exhibited integral and robust after 1 week incubated in 37℃, pH 7.4 phosphate buffer solution with 10 μg/mL proteinase K. Compared with electrospun fibers without PEG-PHOA, the concentration ofproteinase K in release media had less effect on the release rate of ibuprofen. An unique release profile was found from PEG-PLLA fiber after the incorporation of PEG-PHOA. Enzyme degradation experiments demonstrated that PEG-PHOA but not a-hydroxy octanoic acid monomer was the crucial factor for integrity maintenance of the electrospun fibers, which may be due to the enzyme degradation tolerance property of the PEG-PHOA polymer additive.
出处 《Chinese Journal of Polymer Science》 SCIE CAS CSCD 2010年第3期417-425,共9页 高分子科学(英文版)
基金 supported by the National Natural Science Foundation of China(Nos.20274048,50373043) the Chinese Academy of Sciences(No.KJCX2-SW-H07) the"863 project"(No.2002AA326100)
关键词 Poly(ct-hydroxy octanoic acid) Poly(lactic acid) ELECTROSPINNING Fiber IBUPROFEN Drug release Proteinase K. Poly(ct-hydroxy octanoic acid) Poly(lactic acid) Electrospinning Fiber Ibuprofen Drug release Proteinase K.
  • 相关文献

参考文献33

  • 1Biondi,M.,Ungaro,F.,Quaglia,F.and Netti,P.A.,Adv.Drug Deliv.Rev.,2008,60:229.
  • 2Vasir,J.K.and Labhasetwar,V.,Adv.Drug Deliv.Rev.,2007,59:718.
  • 3Kretlow,J.D.,Klouda,L.and Mikos,A.G.,Adv.Drug Deliv.Rev.,2007,59:263.
  • 4Saito,N.,Murakami,N.,Takahashi,J.,Horiuchi,H.,Ota,H.,Kato,H.,Okada,T.,Nozaki,K.and Takaoka,K.,Adv.Drug Deliv.Rev.,2005,57:1037.
  • 5Jilek,S.,Merkle,H.P.and Walter,E.,Adv.Drug Deliv.Rev.,2005,57:377.
  • 6Cerral,P.,Tricoli,M.,Lelli,L.and Guerra,G.D.,J.Mater.Sci.Mater.Med.,1994,5:308.
  • 7Kissel,T.,Li,Y.and Unger,F.,Adv.Drug Deliv.Rev.,2002,54:99.
  • 8Anderson,J.M.and Shive,M.S.,Adv.Drug Deliv.Rev.,1997,28:5.
  • 9Yasukawa,T.,Kimura,H.,Tabata,Y.and Ogura,Y.,Adv.Drug Deliv.Rev.,2001,52:25.
  • 10Vila,A.,Gill,H,McCallion,O.and Alonso,M.J.,J.Control.Release,2004,98:231.

同被引文献14

  • 1董存海,段斌,袁晓燕,姚康德.静电纺丝制备聚丙交酯超细纤维[J].生物医学工程学杂志,2005,22(6):1245-1248. 被引量:5
  • 2陈辰,曹传宝,马西兰,唐茵,朱鹤孙.静电纺丝丝素蛋白水溶液制备无纺布[J].北京生物医学工程,2007,26(1):10-12. 被引量:2
  • 3Thomas Trimaille, Karine Mondon, Robert Gurny, et al. Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly (hexyl-substituted lactides) [ J ]. International Journal of Pharmaceutics, 2006,319( 1 -2) :147 - 154.
  • 4Thomas Trimaille, Michael Moller, Robert Gumy. Synthesis and ring-openning polymerization of new monoalkyl - substituted lactides[ J]. J Polym Sci: Pol Chem,2004,42 : 4379 - 4391.
  • 5Morita T, Horikiri Y, Suzuki T, et al. Applicability of various amphiphilic polymers to the modification of protein release kinetics from biodegradable reservoirtype mierospheres [ J ]. European Journal of Pharmaceutical and Biopharmaceuties ,2001,51:45 - 53.
  • 6Kenawy E R, Bowlin G L, Mansfield K, et al. Release of tetracycline hydrochloride from electrospun poly ( ethylene-co-vinylacetate ) , poly ( lactic acid ) , and a blend[J]. Journal of Controlled Release,2002, 81:57 - 64.
  • 7Xu X L, Chen X S, Jing X B, et al. The release behavior of doxorubicin hydrochloride from medicated fibers prepared by emulsion-electrospinning [ J ]. European Journal of Pharmaceutics and Biopharmaceutics, 2008,70 : 165 - 170.
  • 8Kim K, Luu Y K, Chang C, et al. Incorporation and controlled release of a hydrophilic antibiotic using poly ( lactide-co-glycolide )-based eletrospun nanofibrous scaffolds [ J ]. Journal of Controlled Release, 2004, (98) :47 -56.
  • 9Xu X, Chen X, Xu X , et al. BCNU-loaded PEG-PL- LA ultrafine fibers and their in vitro antitumor activity against Glioma C6 cells [ J ]. Journal of Controlled Release ,2006,114:307 - 316.
  • 10Luu Y K, Kim K, Hsiao B S, et al. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers [ J ]. Journal of Controlled Release ,2003,89:341 - 353.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部